questionsmedicales.fr
Maladies du système immunitaire
Syndromes immunoprolifératifs
Syndromes lymphoprolifératifs
Lymphomes
Lymphome malin non hodgkinien
Lymphome T
Lymphome T : Questions médicales fréquentes
Diagnostic
5
Lymphome T
Biopsie
Imagerie médicale
Immunophénotypage
Analyse cytogénétique
Lymphome T
Symptômes
Lymphome T
Ganglions lymphatiques
Facteurs génétiques
Lymphome T
Hérédité
Tomodensitométrie
IRM
Lymphome T
Symptômes
5
Symptômes
Lymphome T
Fatigue
Sueurs nocturnes
Lymphome T
Symptômes
Douleurs
Lymphome T
Ganglions lymphatiques
Symptômes respiratoires
Lymphome T
Thorax
Éruptions cutanées
Lymphome T
Dermatologie
Prévention
5
Prévention
Lymphome T
Mode de vie sain
Infections
Lymphome T
VIH
Tabagisme
Lymphome T
Facteurs de risque
Produits chimiques
Lymphome T
Exposition
Stress
Lymphome T
Système immunitaire
Traitements
5
Chimiothérapie
Radiothérapie
Lymphome T
Greffe de moelle osseuse
Lymphome T
Traitements
Thérapies ciblées
Lymphome T
Efficacité
Stade du lymphome
Lymphome T
Traitement
Effets secondaires
Lymphome T
Chimiothérapie
Complications
5
Complications
Lymphome T
Infections
Propagation
Lymphome T
Organes
Rechutes
Lymphome T
Traitement
Problèmes neurologiques
Lymphome T
Système nerveux
Gestion
Lymphome T
Suivi médical
Facteurs de risque
5
Facteurs de risque
Lymphome T
Immunodépression
Maladies auto-immunes
Lymphome T
Facteurs de risque
Antécédents familiaux
Lymphome T
Risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lymphome T : Questions médicales les plus fréquentes",
"headline": "Lymphome T : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lymphome T : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-19",
"dateModified": "2026-07-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lymphome T"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lymphome malin non hodgkinien",
"url": "https://questionsmedicales.fr/mesh/D008228",
"about": {
"@type": "MedicalCondition",
"name": "Lymphome malin non hodgkinien",
"code": {
"@type": "MedicalCode",
"code": "D008228",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761.480"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Lymphome T associé à une entéropathie",
"alternateName": "Enteropathy-Associated T-Cell Lymphoma",
"url": "https://questionsmedicales.fr/mesh/D058527",
"about": {
"@type": "MedicalCondition",
"name": "Lymphome T associé à une entéropathie",
"code": {
"@type": "MedicalCode",
"code": "D058527",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761.480.750.199"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lymphome à grandes cellules anaplasiques",
"alternateName": "Lymphoma, Large-Cell, Anaplastic",
"url": "https://questionsmedicales.fr/mesh/D017728",
"about": {
"@type": "MedicalCondition",
"name": "Lymphome à grandes cellules anaplasiques",
"code": {
"@type": "MedicalCode",
"code": "D017728",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761.480.750.399"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lymphome T cutané",
"alternateName": "Lymphoma, T-Cell, Cutaneous",
"url": "https://questionsmedicales.fr/mesh/D016410",
"about": {
"@type": "MedicalCondition",
"name": "Lymphome T cutané",
"code": {
"@type": "MedicalCode",
"code": "D016410",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761.480.750.800"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Lymphome cutané primitif à grandes cellules anaplasiques",
"alternateName": "Lymphoma, Primary Cutaneous Anaplastic Large Cell",
"url": "https://questionsmedicales.fr/mesh/D054446",
"about": {
"@type": "MedicalCondition",
"name": "Lymphome cutané primitif à grandes cellules anaplasiques",
"code": {
"@type": "MedicalCode",
"code": "D054446",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761.480.750.800.507"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Papulose lymphomatoïde",
"alternateName": "Lymphomatoid Papulosis",
"url": "https://questionsmedicales.fr/mesh/D017731",
"about": {
"@type": "MedicalCondition",
"name": "Papulose lymphomatoïde",
"code": {
"@type": "MedicalCode",
"code": "D017731",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761.480.750.800.528"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mycosis fongoïde",
"alternateName": "Mycosis Fungoides",
"url": "https://questionsmedicales.fr/mesh/D009182",
"about": {
"@type": "MedicalCondition",
"name": "Mycosis fongoïde",
"code": {
"@type": "MedicalCode",
"code": "D009182",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761.480.750.800.550"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Réticulose pagétoïde",
"alternateName": "Pagetoid Reticulosis",
"url": "https://questionsmedicales.fr/mesh/D056267",
"about": {
"@type": "MedicalCondition",
"name": "Réticulose pagétoïde",
"code": {
"@type": "MedicalCode",
"code": "D056267",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761.480.750.800.550.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Réticulose pagétoïde",
"alternateName": "Pagetoid Reticulosis",
"url": "https://questionsmedicales.fr/mesh/D056267",
"about": {
"@type": "MedicalCondition",
"name": "Réticulose pagétoïde",
"code": {
"@type": "MedicalCode",
"code": "D056267",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761.480.750.800.550.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Lymphome T périphérique",
"alternateName": "Lymphoma, T-Cell, Peripheral",
"url": "https://questionsmedicales.fr/mesh/D016411",
"about": {
"@type": "MedicalCondition",
"name": "Lymphome T périphérique",
"code": {
"@type": "MedicalCode",
"code": "D016411",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761.480.750.825"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Lymphome T",
"alternateName": "Lymphoma, T-Cell",
"code": {
"@type": "MedicalCode",
"code": "D016399",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Neha Mehta-Shah",
"url": "https://questionsmedicales.fr/author/Neha%20Mehta-Shah",
"affiliation": {
"@type": "Organization",
"name": "Division of Oncology, Department of Medicine, Washington University School of Medicine, 660 S. Euclid, Box 8056, St. Louis, MO, 63110, USA. mehta-n@wustl.edu."
}
},
{
"@type": "Person",
"name": "Steven M Horwitz",
"url": "https://questionsmedicales.fr/author/Steven%20M%20Horwitz",
"affiliation": {
"@type": "Organization",
"name": "Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York City, USA."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Alison J Moskowitz",
"url": "https://questionsmedicales.fr/author/Alison%20J%20Moskowitz",
"affiliation": {
"@type": "Organization",
"name": "Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York City, USA. moskowia@mskcc.org."
}
},
{
"@type": "Person",
"name": "Alain H Rook",
"url": "https://questionsmedicales.fr/author/Alain%20H%20Rook",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology, Cutaneous Lymphoma Program, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, 1st Floor, Philadelphia, PA 19104, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A new mode for the diagnosis of angioimmunoblastic T-cell lymphoma.",
"datePublished": "2024-05-27",
"url": "https://questionsmedicales.fr/article/38814221",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.14715/cmb/2024.70.5.22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Delayed diagnosis of angioimmunoblast T-cell lymphoma presenting with immunoglobulin a vasculitis.",
"datePublished": "2024-10-28",
"url": "https://questionsmedicales.fr/article/39465652",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/0886022X.2024.2416935"
}
},
{
"@type": "ScholarlyArticle",
"name": "Real-world study and prognostic analysis of angioimmunoblastic T-cell lymphoma.",
"datePublished": "2024-10-14",
"url": "https://questionsmedicales.fr/article/39474428",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1481301"
}
},
{
"@type": "ScholarlyArticle",
"name": "Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.",
"datePublished": "2023-08-30",
"url": "https://questionsmedicales.fr/article/37646306",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/bjh.19089"
}
},
{
"@type": "ScholarlyArticle",
"name": "Subcutaneous panniculitis-like T-cell lymphoma and lupus erythematosus profundus: a diagnostic dilemma.",
"datePublished": "2024-06-25",
"url": "https://questionsmedicales.fr/article/38925673",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2023-255592"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Syndromes immunoprolifératifs",
"item": "https://questionsmedicales.fr/mesh/D007160"
},
{
"@type": "ListItem",
"position": 4,
"name": "Syndromes lymphoprolifératifs",
"item": "https://questionsmedicales.fr/mesh/D008232"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lymphomes",
"item": "https://questionsmedicales.fr/mesh/D008223"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lymphome malin non hodgkinien",
"item": "https://questionsmedicales.fr/mesh/D008228"
},
{
"@type": "ListItem",
"position": 7,
"name": "Lymphome T",
"item": "https://questionsmedicales.fr/mesh/D016399"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lymphome T - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lymphome T",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-26",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lymphome T",
"description": "Comment diagnostique-t-on un lymphome T ?\nQuels tests sont utilisés pour confirmer le lymphome T ?\nQuels symptômes peuvent alerter sur un lymphome T ?\nLe lymphome T est-il héréditaire ?\nQuelle imagerie est utilisée pour le lymphome T ?",
"url": "https://questionsmedicales.fr/mesh/D016399#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lymphome T",
"description": "Quels sont les symptômes courants du lymphome T ?\nLes sueurs nocturnes sont-elles un symptôme ?\nLe lymphome T cause-t-il des douleurs ?\nPeut-on avoir des symptômes respiratoires ?\nLes éruptions cutanées sont-elles liées au lymphome T ?",
"url": "https://questionsmedicales.fr/mesh/D016399#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lymphome T",
"description": "Peut-on prévenir le lymphome T ?\nLes infections peuvent-elles augmenter le risque ?\nLe tabagisme est-il un facteur de risque ?\nL'exposition à des produits chimiques est-elle dangereuse ?\nLe stress peut-il influencer le lymphome T ?",
"url": "https://questionsmedicales.fr/mesh/D016399#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lymphome T",
"description": "Quels traitements sont disponibles pour le lymphome T ?\nLa greffe de moelle osseuse est-elle une option ?\nLes thérapies ciblées sont-elles efficaces ?\nLe traitement est-il le même pour tous les lymphomes T ?\nY a-t-il des effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D016399#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lymphome T",
"description": "Quelles sont les complications possibles du lymphome T ?\nLe lymphome T peut-il affecter d'autres organes ?\nLes rechutes sont-elles fréquentes ?\nLe lymphome T peut-il causer des problèmes neurologiques ?\nComment gérer les complications du lymphome T ?",
"url": "https://questionsmedicales.fr/mesh/D016399#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lymphome T",
"description": "Quels sont les principaux facteurs de risque du lymphome T ?\nL'âge influence-t-il le risque de lymphome T ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe sexe joue-t-il un rôle dans le lymphome T ?\nLes antécédents familiaux influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D016399#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un lymphome T ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par biopsie, examens d'imagerie et analyses sanguines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le lymphome T ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'immunophénotypage et l'analyse cytogénétique."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent alerter sur un lymphome T ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes incluent fièvre, sueurs nocturnes, perte de poids et ganglions enflés."
}
},
{
"@type": "Question",
"name": "Le lymphome T est-il héréditaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'est pas directement héréditaire, mais des facteurs génétiques peuvent jouer un rôle."
}
},
{
"@type": "Question",
"name": "Quelle imagerie est utilisée pour le lymphome T ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La tomodensitométrie (TDM) et l'IRM sont couramment utilisées pour évaluer l'étendue."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du lymphome T ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, démangeaisons, douleurs abdominales et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les sueurs nocturnes sont-elles un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les sueurs nocturnes sont fréquentes chez les patients atteints de lymphome T."
}
},
{
"@type": "Question",
"name": "Le lymphome T cause-t-il des douleurs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut provoquer des douleurs, surtout si des ganglions lymphatiques sont touchés."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes respiratoires ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes respiratoires peuvent survenir si le lymphome affecte le thorax."
}
},
{
"@type": "Question",
"name": "Les éruptions cutanées sont-elles liées au lymphome T ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines formes de lymphome T peuvent provoquer des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le lymphome T ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un mode de vie sain peut aider."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles augmenter le risque ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales, comme le VIH, peuvent augmenter le risque de lymphome T."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de plusieurs cancers, y compris le lymphome T."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques est-elle dangereuse ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains produits chimiques peut augmenter le risque de lymphome T."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer le lymphome T ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut affaiblir le système immunitaire, augmentant potentiellement le risque."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le lymphome T ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent chimiothérapie, radiothérapie et thérapies ciblées."
}
},
{
"@type": "Question",
"name": "La greffe de moelle osseuse est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la greffe de moelle osseuse peut être envisagée pour certains patients."
}
},
{
"@type": "Question",
"name": "Les thérapies ciblées sont-elles efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles ciblent spécifiquement les cellules cancéreuses et peuvent être très efficaces."
}
},
{
"@type": "Question",
"name": "Le traitement est-il le même pour tous les lymphomes T ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le traitement varie selon le type et le stade du lymphome T."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les effets secondaires peuvent inclure nausées, fatigue et infections."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du lymphome T ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent infections, insuffisance organique et rechutes."
}
},
{
"@type": "Question",
"name": "Le lymphome T peut-il affecter d'autres organes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut se propager à d'autres organes comme le foie, les poumons et la moelle osseuse."
}
},
{
"@type": "Question",
"name": "Les rechutes sont-elles fréquentes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les rechutes peuvent survenir, nécessitant un traitement supplémentaire."
}
},
{
"@type": "Question",
"name": "Le lymphome T peut-il causer des problèmes neurologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines formes peuvent affecter le système nerveux central, entraînant des symptômes neurologiques."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications du lymphome T ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut un suivi médical régulier et un traitement des symptômes et complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du lymphome T ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe masculin, certaines infections et l'immunodépression."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de lymphome T ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout après 60 ans."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes augmentent le risque de développer un lymphome T."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans le lymphome T ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le lymphome T est plus fréquent chez les hommes que chez les femmes."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de lymphome peuvent augmenter le risque individuel."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 08/07/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Division of Oncology, Department of Medicine, Washington University School of Medicine, 660 S. Euclid, Box 8056, St. Louis, MO, 63110, USA. mehta-n@wustl.edu.
Publications dans "Lymphome T" :
3 publications dans cette catégorie
Affiliations :
Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York City, USA.
Publications dans "Lymphome T" :
3 publications dans cette catégorie
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York City, USA. moskowia@mskcc.org.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, Cutaneous Lymphoma Program, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, 1st Floor, Philadelphia, PA 19104, USA.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, 4500 San Pablo Road, Mangurian Bldg, Jacksonville, FL 32224, USA.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tuebingen, Tuebingen, Germany.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tuebingen, Tuebingen, Germany.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
Section of Hematology and Oncology, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
Division of Dermatology, Department of Surgery, City of Hope National Medical Center, Duarte, California, USA; Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA; Department of Pathology, City of Hope National Medical Center, Duarte, California, USA. Electronic address: cquerfeld@coh.org.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
a Department of Haematology , Peter MacCallum Cancer Centre , Melbourne , Australia.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
a Department of Haematology , Peter MacCallum Cancer Centre , Melbourne , Australia.
c Cancer Immunology Program, Peter MacCallum Cancer Centre , Melbourne , Australia.
d Sir Peter MacCallum Department of Oncology , The University of Melbourne , Parkville , Australia.
e Epworth Healthcare , Richmond , Australia.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, 25 rue du Bugnon, CH- 1011, Lausanne, Switzerland. Laurence.deLeval@chuv.ch.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology and Immunology, Kagoshima University Hospital.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
City of Hope, Duarte, California, United States.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
The Ohio State University James Comprehensive Cancer Center, United States.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
Lymphoma Program, Abramson Cancer Center, United States.
Publications dans "Lymphome T" :
2 publications dans cette catégorie
Affiliations :
Yale University School of Medicine, New Haven, Connecticut.
Publications dans "Lymphome T" :
In order to explore a new mode for the diagnosis of angioimmunoblastic T-cell lymphoma (AITL), 31 cases of AITL and 28 cases of peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) were used...
Although vasculitis and renal involvement might be associated with malignancy, they are rarely associated with lymphoproliferative diseases. We observed a case of immunoglobulin A vasculitis associate...
To analyze the clinical prognostic factors and treatments for angioimmunoblastic T-cell lymphoma (AITL) and develop a novel prognostic model specifically for AITL....
We retrospectively analyzed 231 patients with AITL from the First Affiliated Hospital of Zhengzhou University. Patients were enrolled between January 2014 and July 2023. The primary end points were ov...
The patients' median age was 63 years, with 88.3% at an advanced stage (III/IV). The majority of patients (47.6%) received anthracycline-containing regimens, and there was no significant difference in...
Currently, there is no consensus on the optimal initial therapy for AITL, and the efficacy of anthracycline-containing regimens remains suboptimal. The novel model developed herein demonstrates predic...
Molecular and clinical stratification of patients with angioimmunoblastic T-cell lymphoma (AITL) is unsatisfactory, which hinders the development of personalized therapies. This study aimed to identif...
A white Caucasian woman in her 30s presented with an indurated lesion on her right upper arm. Panniculitis was clinically suspected. Antinuclear antibody testing was positive but incisional biopsy sho...
To investigate the expression of polo-like kinase 1 protein (PLK1) and its phosphorylation level (p-PLK1) in extranodal NK/T cell lymphoma (NKTCL) and their correlation with clinical characteristics a...
We collected 40 cases of NKTCL (referred to as the experimental group), which received diagnoses at the First Affiliated Hospital of Zhengzhou University between January 2018 and October 2022. Concurr...
Among the 40 NKTCL patients, there were 27 males and 11 females, with a median age of 51 years (range 12-80 years). Compared to the control group, the tissue samples of NKTCL patients exhibited signif...
The expression levels and active phosphorylation levels of PLK1 were significantly increased in NK/T cell lymphoma, and patients with overexpression of PLK1 and p-PLK1 had a poorer prognosis....
Panniculitis is an inflammation that occurs in subcutaneous adipose tissue. Panniculitis includes physical panniculitis (e.g., traumatic) and infectious panniculitis (e.g., bacterial, fungal, subcutan...
Angioimmunoblastic T-cell lymphoma (AITL) is known for its unfavorable survival prognosis. Chidamide has shown efficacy in relapsed/refractory AITL, but its efficacy in newly diagnosed AITL is uncerta...
This retrospective research aimed to evaluate the effectiveness and safety of chidamide when used with doxorubicin, cyclophosphamide, prednisone, and vincristine (CHOP) in comparison to CHOP by itself...
This was an analysis that compared outcomes among patients who received chidamide + CHOP on a clinical trial vs. historical controls who received CHOP alone, enrolling a total of sixty-six treatment-n...
The chidamide group had a significantly longer median overall survival (OS) compared to the control group, with a median OS that was not reached, as opposed to 20 months in the control group (p = 0.00...
As the study was non-random and retrospective, Chidamide combined with chemotherapy should be tested in randomized trials given its potential to improve prognosis in treatment-naive AITL patients. Fur...
https://clinicaltrials.gov/, NCT03268889....
The diagnosis of pulmonary lymphoma using small tissue samples is difficult and often requires surgical procedures; thus, a less invasive sampling method is desirable. Moreover, pulmonary involvement ...
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare form of non-Hodgkin lymphoma that primarily affects subcutaneous tissues. Its occurrence in the orofacial region is exceptionally uncom...
This report details the case of a 15-year-old male who presented with persistent left-sided facial swelling, initially misdiagnosed as facial cellulitis. Diagnostic complexity arose from the similarit...
This case underscores the diagnostic challenges of orofacial lymphomas such as SPTCL and highlights the necessity for early, accurate pathological diagnosis. It emphasizes the role of advanced diagnos...